K Pharma,Inc. (4896.T)

JPY 632.0

(-1.25%)

Total Liabilities Summary of K Pharma,Inc.

  • K Pharma,Inc.'s latest annual total liabilities in 2023 was 209.13 Million JPY , up 446.0% from previous year.
  • K Pharma,Inc.'s latest quarterly total liabilities in 2024 Q2 was 111 Million JPY , up 10.19% from previous quarter.
  • K Pharma,Inc. reported annual total liabilities of 38.3 Million JPY in 2022, up 42.52% from previous year.
  • K Pharma,Inc. reported annual total liabilities of 26.87 Million JPY in 2021, down 0.0% from previous year.
  • K Pharma,Inc. reported quarterly total liabilities of 100.73 Million JPY for 2024 Q1, down -51.83% from previous quarter.
  • K Pharma,Inc. reported quarterly total liabilities of 209.13 Million JPY for 2023 FY, up 446.0% from previous quarter.

Annual Total Liabilities Chart of K Pharma,Inc. (2023 - 2021)

Historical Annual Total Liabilities of K Pharma,Inc. (2023 - 2021)

Year Total Liabilities Total Liabilities Growth
2023 209.13 Million JPY 446.0%
2022 38.3 Million JPY 42.52%
2021 26.87 Million JPY 0.0%

Peer Total Liabilities Comparison of K Pharma,Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY 93.559%
PRISM BioLab Co.,LTD 63.41 Million JPY -229.807%
GNI Group Ltd. 26.34 Billion JPY 99.206%
Linical Co., Ltd. 10.3 Billion JPY 97.971%
Trans Genic Inc. 3.81 Billion JPY 94.515%
MEDINET Co., Ltd. 590.2 Million JPY 64.566%
Soiken Holdings Inc. 697.02 Million JPY 69.996%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY 93.077%
AnGes, Inc. 2.78 Billion JPY 92.502%
OncoTherapy Science, Inc. 513.6 Million JPY 59.281%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 99.769%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY 40.801%
NanoCarrier Co., Ltd. 1.64 Billion JPY 87.324%
Carna Biosciences, Inc. 472.35 Million JPY 55.725%
CanBas Co., Ltd. 91.98 Million JPY -127.349%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY 80.877%
RaQualia Pharma Inc. 809.83 Million JPY 74.176%
Chiome Bioscience Inc. 593.73 Million JPY 64.776%
Kidswell Bio Corporation 4.25 Billion JPY 95.084%
PeptiDream Inc. 29.11 Billion JPY 99.282%
Oncolys BioPharma Inc. 566.5 Million JPY 63.083%
Ribomic Inc. 155.8 Million JPY -34.225%
SanBio Company Limited 2.25 Billion JPY 90.725%
Healios K.K. 11.28 Billion JPY 98.147%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY 16.769%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY 43.324%
Delta-Fly Pharma, Inc. 241.49 Million JPY 13.401%
StemRIM 187 Million JPY -11.836%
CellSource Co., Ltd. 677.73 Million JPY 69.142%
FunPep Company Limited 189.32 Million JPY -10.464%
Kringle Pharma, Inc. 596.95 Million JPY 64.967%
Stella Pharma Corporation 1.44 Billion JPY 85.513%
TMS Co., Ltd. 97.68 Million JPY -114.081%
Noile-Immune Biotech Inc. 91.49 Million JPY -128.577%
Cuorips Inc. 200.96 Million JPY -4.067%
Takara Bio Inc. 11.42 Billion JPY 98.169%
ReproCELL Incorporated 741.03 Million JPY 71.778%
PhoenixBio Co., Ltd. 917.71 Million JPY 77.211%
StemCell Institute Inc. 3.85 Billion JPY 94.569%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY 76.979%
CellSeed Inc. 301.04 Million JPY 30.531%